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PREFACE
Animals assemble and maintain a diverse, yet host-specific gut microbial community. In addition 
to characteristic microbial compositions along the longitudinal axis of the intestines, discrete 
bacterial communities form in microhabitats, such as the gut lumen, colon mucus layers and colon 
crypts. In this Review, we examine how spatial distribution of symbiotic bacteria among physical 
niches in the gut impacts the development and maintenance of a resilient microbial ecosystem. We 
consider novel hypotheses for how nutrient selection, immune activation and other mechanisms 
control the biogeography of bacteria in the gut and discuss the relevance of this spatial 
heterogeneity to health and disease.
Humans and other mammals harbor a complex gastrointestinal microbiota, which includes 
all three domains of life (Archaea, Bacteria and Eukaryota). This extraordinary symbiosis, 
formed via a series of exposures to environmental factors, is initiated upon contact with the 
vaginal microbiota during birth1. Abrupt changes during the first year of life follow a pattern 
that corresponds to gestational age in both mice2 and humans3, which suggests that strong 
deterministic processes shape the composition of the microbiota during development. These 
population shifts may be explained by influences from diet, the developing immune system, 
chemical exposures, and potentially founder effects of initial colonizers. Founder effects are 
not well understood in the mammalian gut, but the profound changes in host gene expression 
that occur in response to microorganisms, and the great potential for syntrophic interactions 
between bacteria suggest that early colonizers may have long-term effects on the 
establishment of the microbiota. The immune system imposes selective pressure on the 
microbiota through both innate and adaptive mechanisms such as antimicrobial peptides4, 
secreted immunoglobulin A (IgA)5, and other contributing factors6 (see below). However, 
current research suggests that diet may have the greatest impact on microbiota assembly.
Prior to weaning, breast milk plays a crucial part in shaping the microbial community 
composition via transmission of the milk microbiota to the infant gut7, protection from 
harmful species by secreted maternal antibodies8, and selection for certain species by milk 
oligosaccharides, which can be used by microorganisms as carbon sources9. For example, in 
in vitro competitive growth experiments, Bifidobacterium longum benefits from its ability to 
use fucosylated oligosaccharides that are present in human milk to outgrow other bacteria 
that are usually present in the gut microbiota, such as Escherichia coli and Clostridium 
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perfringens10. Several species of Bacteroides can also utilize fucosylated oligosaccharides as 
carbon sources11, suggesting that their colonization may be aided by prebiotic properties of 
milk. Accordingly, children of mothers with nonfunctional fucosyltransferase 2, an enzyme 
required for fucosylation of milk oligosaccharides, display lower levels of fecal 
Bifidobacteria and Bacteroides species12. The importance of diet in determining the 
composition of the microbial community in the gut is also highlighted by the observation 
that transition to solid foods coincides with establishment of an adult-like microbiota.
The adult intestinal microbiota consists of hundreds to thousands of species, dominated by 
the Bacteroidetes and Firmicutes phyla13. This ecosystem is distinct from that of any other 
microbial habitats that have been surveyed14, and includes many species that exist nowhere 
else in nature, indicating that coevolution of the host with its gut microbial symbionts 
(including commensals and mutualists) has generated powerful selective mechanisms. A 
recent study of how different microbial communities colonize gnotobiotic animals showed 
that deterministic mechanisms (presumably host-microorganism interactions) led to 
reproducible shaping of the microbiota regardless of the source of the input community15.
The adult intestinal microbiota is also partially stable, as a core of ~40 bacterial species 
(accounting for 75% of the gut microbiota in terms of abundance) persists for at least a year 
in individuals16. A more extensive longitudinal study found that 60% of all bacterial strains 
within an individual persisted for five years17. During severe perturbations such as antibiotic 
treatment, the fecal community is depleted to a low-diversity consortium, but after a 
recovery period membership and relative abundance largely resemble the pretreatment 
state18. Some species that are depleted to undetectable levels in stool are later recovered18, 
suggesting that there may be reservoirs of bacterial cells that can re-seed the intestinal 
lumen.
The mucus layer, crypts of the colon and appendix are examples of privileged anatomical 
sites, protected from the fecal stream and accessible only to certain microorganisms. In this 
Review, we highlight relevant features of spatial heterogeneity of bacterial species and 
communities in the gut microbiota, and discuss the impact of microbial localization in 
engendering specific and stable colonization with profound implications for health and 
disease.
MICROBIAL COMPOSITION OF THE GUT
The mammalian lower gastrointestinal tract contains a variety of distinct microbial habitats 
along the small intestine, cecum, and large intestine (colon). Physiological variation along 
the lengths of the small intestine and colon include chemical and nutrient gradients, as well 
as compartmentalized host immune activity, which are known to influence bacterial 
community composition. For example, the small intestine is more acidic, and has higher 
levels of oxygen and antimicrobials than the colon (Figure 1A). Therefore, the small 
intestine microbial community is dominated by fast-growing facultative anaerobes that 
tolerate the combined effects of bile acids and antimicrobials, while still effectively 
competing for simple carbohydrates that are available in this region of the gastrointestinal 
tract. Bile acids, secreted through the bile duct at the proximal end of the small intestine, are 
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bactericidal to certain species due to their surfactant properties and are known to broadly 
shape the composition of the microbiota, especially in the small intestine. For example, 
feeding mice excess bile acids generally stimulates the growth of Firmicutes and inhibits 
Bacteroidetes19. Additionally, the shorter transit time in the small intestine compared to 
colon (an order of magnitude shorter, despite the increased length of the small intestine) is 
thought to make bacterial adherence to tissue or mucus an important factor for persistent 
colonization of the small intestine.
In ileostomy samples from humans, the small intestine was found to exhibit lower bacterial 
diversity than the colon, and was highly enriched in certain Proteobacteria and Clostridium 
species20. Furthermore, a metatranscriptomic analysis revealed that the expression of genes 
involved in central metabolism and in pathways responsible for import of simple sugars by 
facultative anaerobes was greatly enriched in ileal samples, compared to fecal samples20. In 
mice, Lactobacillaceae and Proteobacteria (especially Enterobacteriaceae) are enriched in 
the small intestine21 (Figure 1A). Although bacteria in the small intestine are potentially 
competing with the host for nutrients, host-derived bile acids and antimicrobial peptides 
limit bacterial growth to low densities in proximal regions. Only at the distal end of the 
small intestine (in the terminal ileum) do bacterial densities reach saturating levels similar to 
those found in the large intestine (Figure 1A).
The cecum and colon cultivate the most dense and diverse communities of all body habitats. 
Mice, like most herbivorous mammals, have a large cecum between the small and large 
intestine where plant fibers are slowly digested by the microbiota. Humans have a small 
pouch-like cecum with an attached appendix, a thin tube-like extension (Figure 1A). In the 
cecum and colon, microorganisms are responsible for the breakdown of otherwise ‘resistant’ 
polysaccharides that are not metabolized during transit through the small intestine. Lower 
concentrations of antimicrobials, slower transit time, and a lack of available simple carbon 
sources facilitate the growth of fermentative polysaccharide-degrading anaerobes, notably 
those of the high-abundance families Bacteroidaceae and Clostridiaceae. In the mouse, the 
cecum is enriched in Ruminococcaceae and Lachnospiraceae, while the colon is enriched in 
Bacteroidaceae and Prevotellaceae21. Rikenellaceae are prominent in both the cecum and 
colon21. Various host factors drive community differences over the cross-sectional axis of 
the gut. The entire wall of the colon folds over itself, creating compartments between folds 
(inter-fold regions) that are distinct from the central lumenal compartment (Figure 1B). In 
mouse studies that used laser capture microdissection to profile the composition of the 
microbial communities in discrete regions, significant differences were observed between 
the central lumen compartment and the inter-fold region22,23. Specifically, the Firmicute 
families Lachnospiraceae and Ruminococcaceae were enriched between folds while the 
Bacteroidetes families Prevotellaceae, Bacteroidaceae, and Rikenellaceae were enriched in 
the digesta22. Relative to the digesta, the inter-fold regions are likely to contain greater 
amounts of mucus, which can serve as a nutrient source for certain bacteria.
Gut microhabitats: mucus and colon crypts
Throughout the human small intestine and colon, specialized epithelial cells called goblet 
cells secrete a mucus layer of varying thickness that partially or fully covers the epithelium 
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depending on the region, creating a boundary between the gut lumen and host tissue (Figure 
2A and 2B). The small intestine harbors a single, tightly-attached mucus layer (Figure 2A), 
whereas in the colon, mucus is organized into two distinct layers: an outer, loose layer, and 
an inner, denser layer that is firmly attached to the epithelium (Figure 2B). As mentioned 
above, bacterial densities are much higher in the colon, compared to the small intestine, and 
examination of the colon by fluorescence in situ hybridization (FISH) has shown that the 
inner mucus layer appears essentially sterile next to the densely populated outer layer24. In 
addition to mucus density itself serving as a physical obstacle for microorganisms, 
antimicrobial molecules and oxygen secreted from the epithelium accumulate higher local 
concentrations within the mucosa, especially in the small intestine, greatly restricting 
potential microbial inhabitants.
Mucus is continuously secreted and the outer layers are sloughed off, generating ‘islands’ of 
mucus that are carried into the fecal stream25. In mice, a viscosity gradient of the gel-
forming mucus increases from the proximal colon (which includes the cecum and the 
ascending and transverse colon) to distal colonic sites (which includes the descending colon 
and the sigmoid colon that connects to the rectum). Accordingly, there are more mucus-
associated bacteria in the proximal region26. Mucosal biofilm formation in the proximal 
colon is conserved from mammals to amphibians27, suggesting an ancient, evolutionarily 
conserved origin of this region for interactions with bacteria. Therefore, the mucus layers of 
the gastrointestinal tract create environments that are distinct, protected habitats for specific 
bacterial ecosystems that thrive in proximity to host tissue.
Divergence between the mucosal and digesta-associated colonic communities has been 
observed in several mammals including humans28, macaques29, mice30, cows31, and flying 
squirrels32. More specifically, human colon biopsy and swab samples have revealed a 
distinct mucosal community enriched in Actinobacteria and Proteobacteria compared to the 
lumen community33. Certain species are highly enriched in colon mucus, such as the mucin-
degraders Bacteroides acidifaciens in mice34, Bacteroides fragilis in macaques29, and 
Akkermansia muciniphila in mice and humans34,35 (Figure 2B). Human mucosal 
communities in biopsy36–38 and lavage39 samples of the colon contain significant variability 
between sample locations less than one centimeter apart, suggestive of the existence of 
mucosal microbial populations in patches. Interestingly, an imaging study using approaches 
that carefully preserve the structure of feces also identified discrete patches; individual 
groups of bacteria were found to spatially vary in abundance from undetectable to saturating 
levels25. This spatial niche partitioning in feces may be reflective of aggregates of 
interacting microorganisms, heterogeneity of nutrient availability in plant fibers, or 
microenvironments in mucosally-associated communities that imprint the digesta as it 
transits through the gut. Therefore, microbial profiling of fecal samples, which is the most 
common strategy employed in microbiome studies, represents an incomplete and skewed 
view of even the colon, which has distinct mucosal communities and spatial heterogeneity 
that is lost upon sample homogenization.
Some bacteria completely penetrate the mucus and are able to associate directly with the 
epithelium, within the crypts of the colon. Crypt-associated microorganisms were first 
described using electron microscopy40,41. Many subsequent imaging studies likely failed to 
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observe or underestimated the number of tissue-associated bacteria because common 
washing and fixing methods can remove mucosal biofilms42. This led to the hypothesis that 
the mucosal surface is largely devoid of microbial colonization in healthy individuals. 
However, imaging studies using Carnoy’s fixative, which is known to preserve the mucosal 
layer, found that there are bacteria in a significant fraction of colonic crypts in healthy 
mice43 and humans44. More recent work using laser microdissection and sequencing to 
profile mouse crypt-associated communities revealed that the community is especially 
dominated by Acinetobacter spp. and is generally enriched for Proteobacteria capable of 
aerobic metabolism23 (Figure 2B). Evasion of immune responses and particular metabolic 
activities are likely required for crypt occupancy by microorganisms specialized to reside in 
close proximity to the host. A well-characterized example of this adaptation is the ability of 
the human symbiont B. fragilis to enter crypts of the proximal colon of mice via a process 
requiring both modulation of the immune system45 and utilization of specific host-derived 
nutrients46 (see below). While dogma has emerged that microorganisms contact mucosal 
surfaces exclusively in disease states, it appears that life-long physical associations between 
specific members of the microbiota and their hosts represent symbioses forged over 
millennia of co-evolution.
MECHANISMS RESPONSIBLE FOR GUT BIOGEOGRAPHY
Several factors influence the biogeography of bacteria within the gut, including diet, 
antimicrobials, mucus and adherence, and the host immune system.
Diet and nutrients
Bacterial metabolism in the gut likely contributes to the localization of particular groups of 
microorganisms. Because fatty acids and simple carbohydrates from food are absorbed and 
depleted during transit through the small intestine, sustainability of the colonic bacterial 
ecosystem requires growth by fermentation of complex polysaccharides, the principal 
carbon sources that reach the colon. Best studied in this regard are Bacteroides species, 
which are able to catabolize polysaccharides derived from the diet and from the host47. 
Compared to other gut bacteria, Bacteroides have the largest number and diversity of genes 
involved in polysaccharide degradation48. This extensive array of polysaccharide utilization 
systems is dominated by those resembling the starch utilization system (Sus), originally 
described in Bacteroides thetaiotaomicron 49. Sus systems consist of lipid-anchored 
enzymes either secreted or displayed on the bacterial cell surface that can catabolize 
particular complex glycans into smaller oligosaccharides, which are then imported through a 
dedicated outer membrane transporter (Figure 3A). In the gut, Bacteroides species use Sus-
like systems to break down dietary polysaccharides and host-derived mucin glycans50. The 
genome of B. thetaiotaomicron encodes 88 Sus-like systems presumably with different 
glycan specificities, providing remarkable metabolic flexibility51. Based on these findings, 
Bacteroides species, and B. thetaiotaomicron in particular, are sometimes referred to as 
“generalists,” capable of occupying a variety of metabolic niches depending on the 
availability of diverse polysaccharide nutrients.
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Diet-derived polysaccharides control microbial community composition in the lumen of the 
colon. Unsurprisingly, the influence of diet is readily apparent in studies that profile the fecal 
community. A study of humans that completely switched between plant and animal-based 
diets showed that the microbiome abruptly shifts with diet52. Over small time scales this 
effect is reversible, suggesting that these changes represent transient ecosystem adaptations 
via blooms of particular species in the lumen while the mucosal reservoir remains 
unchanged. Many studies of Bacteroides glycan metabolism have shown that restricting the 
polysaccharide content of the mouse diet allows selection for species (or strains) that are 
capable of metabolizing the complex glycans present, such as fructans53, human milk 
oligosaccharides11, fucosylated mucin glycans54, and mannan55. Presumably, the variety of 
Sus-like systems present in the genomes of Bacteroides provides the metabolic plasticity to 
persist in the gut despite short and long-term changes in nutrient availability. However, even 
in terms of monosaccharide and disaccharide utilization, there is a hierarchy of bacteria that 
are more efficient consumers, which helps explain how diet can dramatically and rapidly 
change the composition of the fecal community. Importantly, the nutrient environment of the 
gut lumen may be in a dynamic state of flux due to potential meal-to-meal variability, 
especially in omnivorous mammals.
In contrast to the variable conditions in the gut lumen, mammals likely maintain a more 
consistent nutrient balance in the mucosa, which serves as a stable positive selection factor 
for certain species of bacteria. Mucus degradation and metabolism by gut microorganisms 
provides access to privileged spatial niches and therefore a competitive advantage over other 
species, both indigenous and invasive. For example, several studies have shown that the 
ability to grow in an in vitro mucus culture is generally predictive of the ability of a bacterial 
species to colonize the mouse gut56,57. MUC2 alone is coated with over 100 different O-
linked glycan structures in humans58. These glycans differ between mice and humans59, and 
differences in complex glycan “preference” by various bacterial species is a suggested 
mechanism of host-specific selection of a characteristic microbiome profile. In agreement, 
computational models have shown that positive selection at the epithelium via the ability to 
metabolize specific nutrients can be a more powerful mechanism for shaping host-associated 
microbial communities than negative selection driven by antimicrobials60.
A. muciniphila, a prominent symbiont in many mammals, is one of the most effective mucin 
degraders in vitro35 and is consistently found at high abundance in the mucus layer in 
humans35 and mice34. Consumption of mucus glycans as a carbon and energy source allows 
A. muciniphila and other mucin-degraders to colonize the gut independently of the animal’s 
diet, providing a clear advantage to the bacteria during conditions of nutrient deprivation. 
Accordingly, levels of A. muciniphila increase in fasting Syrian hamsters61 and hibernating 
ground squirrels62. Similarly, during intestinal inflammation in mice, the community 
metatranscriptome indicates increased mucin utilization with a corresponding increase in 
abundance of the mucin-degrading B. acidifaciens63. In gnotobiotic mice, restriction of 
complex polysaccharides in the diet causes the generalist B. thetaiotaomicron to shift its 
metabolism to utilize mucin glycans50. Further work has revealed that mutations in Sus-like 
systems involved in mucin glycan utilization in B. thetaiotaomicron cause a defect in 
competitive colonization and in vertical transmission of bacteria from mother to pup64. 
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Therefore, the ability to utilize mucus as a carbon and energy source contributes to the 
ability of some microorganisms to stably colonize the host and transfer to offspring across 
generations. Not surprisingly, genetic manipulation of enteric mucus production in mice 
changes microbial community composition54,65. In turn, gut bacteria affect transcription of 
mucin-encoding genes in mice66. Overall, development of a healthy mucosa is a 
collaborative, bi-directional event between the host and the gut microbiota, creating an 
environment that allows the specific members to establish persistent colonization via 
utilization of host-derived glycans.
In some cases, the ability of a bacterium to colonize the gut may be determined by its ability 
to utilize a specific, yet limiting, nutrient. Bacterial species-specific carbohydrate utilization 
systems termed commensal colonization factors (CCFs) have been identified in B. fragilis 
and Bacteroides vulgatus, and allow these bacteria to colonize saturable nutrient niches46. 
This discovery was made based on the observation that gnotobiotic mice colonized with a 
specific Bacteroides species are resistant to colonization by the same species, but not 
colonization by closely related species. A genetic screen revealed that a set of genes 
encoding the CCF system was required for this intra-species colonization resistance 
phenotype (Box 1), suggesting that CCFs are responsible for defining the species-specific 
niche. Accordingly, when the ccf genes from B. fragilis were expressed in B. vulgatus, the 
resulting hybrid strain gained the ability to colonize an alternate niche. The CCF system was 
also required for penetration of B. fragilis into the crypts of the colon and long-term 
resilience to intestinal perturbations such as antibiotic treatment and gastroenteritis. 
Collectively, these data suggest that while metabolic flexibility allows bacterial adaptation in 
the lumen environment, the occupation of a narrowly-defined, tissue-associated niche is 
likely very important for stable colonization by some bacteria.
Box 1
Colonization resistance
One of the benefits afforded by the microbiota to the host is colonization resistance to 
pathogens. Invasive species of bacteria are inhibited from colonizing the gut because they 
are unable to displace indigenous species that have gained a strong foothold. After years 
of studying colonization resistance against pathogens in gnotobiotic animals in the 
1960’s and 70’s, Rolf Freter theorized that the ability of a bacterial species to colonize 
the gut is determined by its ability to utilize a specific, limiting nutrient135. This notion 
has been well supported by studies showing that colonization resistance to pathogens is 
mediated by the availability of nutrient niches in the cases of Escherichia coli136 and 
Clostridium difficile137. But Freter’s hypothesis reached even further, suggesting that the 
relative amounts of limiting nutrients could dictate the abundance of each species in the 
indigenous community. Correspondingly, the variety of host-derived growth substrates 
could explain the stable diversity of the gut microbiota if individual species have evolved 
to specialize in the uptake and metabolism of specific, limiting nutrients, such as in the 
case of Bacteroides fragilis46. The concept of spatial niche partitioning being governed 
by host production of specific and scarce nutrient resources is attractive, and may help 
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explain both long-term persistence and resilience of the microbiome, as well as 
colonization resistance to pathogens.
Antimicrobials
Specialized epithelial immune cells called Paneth cells reside at the base of the crypts of the 
small intestine, secreting an array of antimicrobials that restrict the growth of bacteria that 
are found near the mucosal surface4. Many of these molecules are cationic antimicrobial 
peptides that interact with and disrupt negatively charged bacterial membranes (Figure 3B). 
Modifications to lipid A, a major component of the outer membrane of gram-negative 
bacteria, are known to confer resistance to cationic antimicrobial peptides in several 
pathogens67. Interestingly, underphosphorylation of this lipid portion of LPS, a modification 
shared with the pathobiont Helicobacter pylori, was found to be important for resilient 
colonization by B. thetaiotaomicron during inflammation68 (Figure 3B).
The concentration of a variety of antimicrobials is higher toward the proximal end of the 
small intestine, creating a gradient that leads to a higher abundance and diversity of bacteria 
in distal locations (Figure 1A). For example, the lectin RegIIIγ is bactericidal to gram-
positive bacteria that dominate the small intestine because it binds to and disrupts their 
exposed peptidoglycan layer. RegIIIγ is required to prevent massive infiltration of the 
mucosa and microbial invasion of the tissue69. In addition to RegIIIγ, the innate immune 
system deploys many other antimicrobials (such as alpha-defensins from Paneth cells and 
beta-defensins from neutrophils) with differing specificities to limit access to the 
epithelium70, and resistance to these host-derived antimicrobial peptides is a general feature 
of many indigenous gut species of Firmicutes and Bacteroidetes68.
In addition to these antimicrobials, gut bacteria, which are largely anaerobic, must contend 
with reactive oxygen species produced by aerobic host metabolism. Rapid dilution and 
consumption of oxygen secreted from the host tissue generates a gradient of oxygen that 
decreases in concentration from tissue to lumen (Figure 2). Accordingly, the mucosal 
community is enriched in genes required for resistance to reactive oxygen species33. 
Notably, although all Bacteroides species are classified as obligate anaerobes, B. fragilis can 
use oxygen as a terminal electron acceptor at nanomolar concentrations71. B. fragilis and 
tissue-associated microaerophilic Lactobacillaceae express catalase, superoxide dismutase, 
and other enzymes to inactivate reactive oxygen species72. Altogether, these mechanisms 
restrict access to the epithelium to a subset of bacterial species that not only can utilize 
nutrients found only at the tissue boundary, but can survive host antimicrobial strategies as 
well.
Mucus and adhesion
To access the epithelium, pathogens and commensals alike must contend with the mucus 
barrier and the immune system (Figure 4). Secreted MUC2 forms peptide crosslinks to 
create a viscous gel-like substance73, serving as a barrier and host defense mechanism74. In 
mice lacking MUC2, the crypts of the colon are filled with bacteria and the tissue is covered 
in biofilms24, indicating that the gel-forming mucus is the primary barrier to tissue 
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association by the microbiota at large. However, certain bacteria are able to penetrate the 
mucus by swimming or eating their way through.
In the gut, bacterial motility is generally restricted due to the immunogenicity of flagellin, 
which is a ligand for Toll-like Receptor 5 (TLR5)75, and the viscosity of mucus limits the 
effectiveness of swimming (Figure 4). Still, the enteric pathogen Salmonella enterica 
subspecies enterica serovar Typhimurium depends on flagella and chemotaxis to penetrate 
the mucus layer and to reach host tissue76. E. coli and close relative Shigella flexneri opt for 
an alternative strategy of secreting a mucin-binding serine protease, Pic, which rapidly 
digests mucus (Figure 4). Interestingly, Pic also causes hypersecretion of mucus, which may 
interfere with the ability of indigenous bacteria to compete with the pathogen77. Similarly, 
another family of mucus-degrading proteins, M60-like peptidases, are conserved in 
pathogens and commensal mucosal bacteria from the Proteobacteria, Firmicutes, 
Bacteroidetes, and other phyla78. In enterotoxigenic E. coli, an M60-like peptidase was 
required for association with villi in the mouse small intestine79.
In addition to the ability to penetrate the mucus layer, bacterial adhesion to the epithelium 
also influences the microbial composition of the gut, especially in the small intestine (Figure 
2A). Species of Helicobacter adhere to and colonize the the stomach and small intestine 
tissue via adherence to epithelial surface glycans80. Further downstream in the small 
intestine, segmented filamentous bacteria (SFB) adhere intimately to the epithelial surface, 
as first described in imaging studies of mice81. Host-specific strains of SFB appear to be 
present in many mammals, including humans82. These bacteria were only recently cultured 
in vitro using tissue-cultured enterocytes as a platform to support their growth, reinforcing 
the idea that they are obligate symbionts with the mammalian gut tissue83. Their mechanism 
of attachment is still a mystery, though the attachment site is marked by accumulation of 
actin and leaves a visible indentation on the surface of the epithelial cell following removal 
of the filaments83. By virtue of intimate host association, SFB shape the host immune 
response84 and impact autoimmune disease in mouse models85,86.
The molecular mechanisms underlying how microorganisms attach to host tissue have been 
well-studied in pathogens (reviewed in Ref 87). Although all of these features were initially 
discovered and described in pathogens, they are found in many commensal bacteria. 
Bacteria adhere to mucus and epithelial surfaces by deploying outer membrane proteins, 
capsules, lectins, adhesins, and fimbriae (attachment pili) (Figure 4). For example, the non-
invasive pathogen Vibrio cholerae forms a layer of adhered cells on the wall of the small 
intestine using toxin-coregulated pili (TCP) 88. V. cholerae also binds mucins using an outer 
membrane N-acetyl-D-glucosamine (GlcNAc)-binding protein, which may also facilitate 
penetration of the mucus and access to the epithelium89. Without attachment, these naturally 
plankton-associated marine bacteria are unable to colonize the gut, and thus are avirulent. E. 
coli possesses a great number of lectins with diverse sugar specificities allowing it to bind 
mucins as well as other glycoproteins and extracellular matrix components of epithelial 
cells90. Invasive pathogens also depend on adherence factors as a preceding step to 
penetration and infection of the tissue. Listeria monocytogenes expresses a surface protein, 
internalin A, which binds epithelial E-cadherin (a host cell adhesion protein) as a first step 
before exploiting actin to induce phagocytosis91. Studies of S. Typhimurium also reveal a 
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critical role of apical surface attachment in inducing neutrophil-mediated inflammation, 
which appears to paradoxically promote infection92 by providing a competitive advantage 
for the pathogen over the resident microbiota93.
Beneficial microorganisms also adhere to particular regions of the epithelium and can serve 
to exclude adherent pathogens by occupying limited binding sites, although little is known 
about the underlying mechanisms or functions of this process (Box 1). Early imaging studies 
revealed that Lactobacillus spp. that form adherent layers on the epithelium in the rat 
stomach prevent yeast94 and staphylococcal95 adherence to the epithelium. Members of the 
family Lactobacillaceae (such as Lactobacillus and Lactoccocus) that colonize the small 
intestine and stomach have become model systems for studying adhesion by commensals, 
with exopolysaccharides, pili, and cell wall-anchored proteins found to be involved in 
interacting with mucus, extracellular matrix proteins, and other molecular targets on the 
epithelial cell surface96. Notably, cell wall-anchored mucus-binding proteins (MUBs) unique 
to lactobacilli are known to be involved in both adherence and aggregation97. Strain-specific 
diversity in adherence and aggregation factors underlies the host specificity of Lactobacillis 
reuteri, indicating that tissue-associated biofilm formation is fundamental to colonization by 
this species98. Other means of attachment involve mechanisms conserved with pathogens, 
such as adhesive pili in Lactobacillus rhamnosus that bind mucus99. Analogous mechanisms 
can be found in unrelated species such as Bifidobacterium bifidum, which uses pili to bind 
extracellular matrix proteins, contributing to bacterial aggregation100.
Collectively, these studies suggest that interactions with mucus and adherence to intestinal 
epithelial cells appear to be adaptations used by pathogens during infection, as well as 
strategies employed by commensals during persistent colonization (Figure 4).
Immunomodulation
In order to persist in the gut, non-pathogenic bacteria that intimately associate with host 
tissue must be tolerated by the immune system. The mucosa is inundated with large amounts 
of secreted Immunoglobulin A (sIgA) to monitor the microbiota. Many bacteria in the gut 
are coated in sIgA, and this subpopulation broadly resembles the mucosal population101. 
Certain adherent species such as Helicobacter spp. and SFB are especially highly coated in 
sIgA102. Binding of sIgA to bacteria may contribute to mucosal biofilm formation, which 
serves as a barrier to pathogen adherence103. Gnotobiotic studies with Rag1 knockout mice 
(which effectively have no adaptive immune system) showed that experimental coating of B. 
thetaiotaomicron with sIgA reduces microbial fitness but also leads to reduced inflammatory 
signaling and changes to bacterial gene expression5,104. Through these mechanisms, sIgA 
mediates homeostasis between the host and the microbiota, as well as potential pathogens at 
mucosal surfaces. Furthermore, natural antibodies have evolved to recognize bacterial 
capsular polysaccharides; while largely studied in the context of infectious agents, such 
antibodies may also represent an evolutionarily conserved strategy used by the host to sense 
indigenous bacterial species. However, examples on how the immune system can 
dependably distinguish between harmful and beneficial microorganisms remain limited.
An alternate view is that the immune system is not “hard-wired” to discriminate between 
various classes of microorganisms, but rather that specific species have adapted to promote 
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their own immunologic tolerance. A few examples of active, species-specific 
immunomodulation by beneficial microorganisms suggest that some bacteria display signals 
that ensure their own tolerance by the immune system (Figure 5). B. fragilis is one of the 
best-understood gut bacteria in terms of immunomodulation. A component of its capsule, 
polysaccharide A (PSA), signals through an antigen-presenting cell intermediary to 
stimulate production of IL-10 by an anti-inflammatory subset of immune cells, regulatory T 
cells105, contributing to the ability of B. fragilis to enter the mucus layer of the colon45 
(Figure 5). Surface fucosylation of the bacterial capsule also contributes to B. fragilis fitness 
in the gut, perhaps by mimicking the host cell surface to elicit a tolerogenic immune 
response106. Through these specific molecular signals, B. fragilis induces an anti-
inflammatory immune profile that facilitates its own colonization. Similarly, 
exopolysaccharides of Bifidobacterium breve promote immune tolerance by decreasing the 
production of pro-inflammatory cytokines and preventing a B-cell response107 (Figure 5). 
Through a less well-defined mechanism, B. breve also induces IL-10 production by 
regulatory T cells108. Notably, both B. fragilis and species of Bifidobacterium are known to 
closely associate with the host, which may necessitate immunomodulation to prevent an 
inflammatory reaction against these bacteria. Similarly, adherent SFB stimulate the 
development of a subset of T helper cells, Th17 cells, which are required for normal SFB 
colonization and also confer resistance to the pathogen Citrobacter rodentium84 (Figure 5; 
Box 1). Clostridia are able to induce regulatory T cells, but a population of many species is 
much more effective than single isolates or combinations of a few, suggesting this is a 
combined effect of production of different metabolites, such as short chain fatty acids, by 
different species (see below)109 (Figure 5). Similarly, a defined community of eight mouse 
gut bacterial species (including several members of families Clostridiaceae and 
Lactobacillaceae) referred to as the altered Schaedler’s flora110, was also shown to modulate 
immune responses mediated by regulatory T cells. Therefore, it is likely that many other 
beneficial microorganisms have co-evolved with the immune system to facilitate stable long-
term colonization.
Several non-specific signals in the gut also promote tolerance towards beneficial 
microorganisms. Short chain fatty acids such as butyrate, propionate, and acetate are the 
end-products of anaerobic fermentation of sugars, which is the dominant metabolism in the 
colon. The development of regulatory T cells is stimulated by these molecules111,112, which 
could be a more general way for the immune system to recognize beneficial bacteria or to 
assess the total fermentative productivity of the community. Mucus is another non-specific 
anti-inflammatory signal. When MUC2 is taken up by dendritic cells in mice, it inhibits the 
expression of pro-inflammatory signals113, raising the possibility that indigenous mucin-
degraders may induce host tolerance by being co-presented with mucus. Pathogens also have 
an arsenal of anti-inflammatory mechanisms to suppress the immune system to promote 
infection114. Particularly perplexing is the fact that features traditionally regarded as 
virulence factors in pathogens, such as capsular polysaccharides and pili, are also 
colonization factors in beneficial bacteria. Our notion of the defining characteristics of 
pathogens is likely clouded by a historical under-appreciation of similar colonization 
strategies used by beneficial species (Figure 4). It is not surprising that similar mechanisms 
of host association (mucus penetration, adherence, immune modulation) are used by 
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pathogenic and commensal bacteria alike; however, a key distinguishing feature is that 
commensals have either not evolved traits resembling traditional virulence factors, or have 
evolved additional features or modifications to offset the host-response to such factors. This 
perspective suggests that commensal bacteria may have reached an immunologic and 
metabolic ‘truce’ with their host, enabling persistent establishment of defined microbial 
habitats and elaborate microbial biogeographies.
MICRO-BIOGEOGRAPHY IN HEALTH AND DISEASE
Microhabitats in the gut are likely to contribute to the development and stability of microbial 
communities because spatially stratified niches facilitate greater diversity. In mouse pups, 
the fecal microbiota is initially dominated by Proteobacteria, a signature of the small 
intestine, but switches following weaning to Clostridia and Bacteroides, which are 
characteristic of the adult colon2. The sequential development of the microbiota thus may 
occur from proximal to distal compartments, which makes sense as dispersal in the gut is 
largely unidirectional along the fecal stream. Because of this restriction on dispersal, 
depletion of beneficial species, especially in the colon, could be catastrophic without a 
mechanism to replenish the community. Therefore, protected regions that are less 
susceptible to variable conditions in the gut may serve as reservoirs of bacterial cells that can 
seed growth in the lumen, possibly after an environmental insult (Figure 6). In the case of B. 
fragilis, mutants that are unable to colonize the crypts of the colon are less resilient to 
intestinal perturbations such as antibiotic treatment and enteric infection46. This is also a 
proposed function of the human appendix, which has a mucus and bacteria-filled lumen 
contiguous with the cecum115. The appendix is protected from the fecal stream, yet harbors 
a diverse microbial community and a contingent of specialized immune cells. The appendix 
is also phylogenetically widespread and evolved independently at least twice, providing 
strong evidence that this is not a vestigial structure as once believed27. In the rabbit 
appendix, indigenous bacteria coordinate the education of B and T-lymphocytes, suggesting 
that these tissue-associated niches are venues for immunomodulation116. Microhabitats such 
as crypts, mucus, and the appendix may be crucial to facilitate immune homeostasis, to 
protect microbial inhabitants from competitors, and to re-populate the gut following 
catastrophic perturbations that alter bacterial community structure or deplete certain species 
from the lumen.
Micro-biogeography alterations during disease
The adverse effects of altered composition of the healthy microbiota, known as dysbiosis, on 
host health have long been appreciated. Increasing clinical evidence links dysbiosis with 
various immune, metabolic, and neurological disorders in both intestinal and extra-intestinal 
sites. For example, inflammatory bowel disease (IBD) is associated with changes in the gut 
microbiota, characterized by decreased abundance of Clostridia117–119 and overall reduction 
in bacterial diversity118–120. Childhood asthma is correlated with low intestinal microbial 
diversity during the first month of life121. The obesity-associated microbiota is characterized 
by reduced microbial diversity and, in some studies, an increased Firmicutes:Bacteroidetes 
ratio122. In recent years, the role of gut dysbiosis in the pathogenesis of chronic liver 
diseases 123,124, colorectal cancer (CRC) 125,126, and even neuropsychiatric dysfunctions127 
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has been explored in animal models and humans. For clinical applications, profiling of the 
fecal microbiota has been widely used as a surrogate for the gastrointestinal bacterial 
community due to non-invasive and straightforward sample collection; however, fecal 
populations may be less informative than mucosal biopsies in defining disease-associated 
dysbiosis128, a notion that requires additional experimental support. Below, we detail two 
examples that illustrate the importance of micro-biogeography alterations of the gut 
microbiota during disease: IBD and hepatic encephalopathy.
IBD is characterized by inflammation of the gastrointestinal tract resulting in pain, vomiting, 
diarrhea, and other complications including severe weight loss and behavioral changes. 
Generally IBD is categorized into two syndromes, Crohn disease, which may involve 
inflammation throughout the gastrointestinal tract (mouth to anus), and ulcerative colitis, 
where pathology is restricted to the large intestine. For over a decade, studies have attempted 
to define a pattern of dysbiosis associated with IBD and yielded inconsistent and sometimes 
contradicting results129. Studies that focused on fecal microbiota reported wide inter-
individual differences in composition with overall microbial diversity reduced118 in Crohn 
disease patients compared to healthy controls. However, a study in which human gut 
microbiota were assessed for the ability to drive colitis pathology in mice found that bacteria 
contributing to the disease are highly coated in sIgA102, suggesting that the mucosal or 
tissue-associated population is most relevant. Human studies based on biopsy samples 
elucidated several consistent features in line with this hypothesis: patients had increased 
concentration of bacteria on the mucosal surface130; decreased microbial diversity; 119,120; 
decreased abundance of Clostridium species 117; and increased number of 
Enterobacteriaceae (especially adherent, invasive E. coli) in ileal mucosa131. Most recently, 
both the lumen- and mucosa-associated microbiota were profiled in a large cohort of new-
onset, treatment naïve pediatric patients with Crohn disease and non-IBD controls. Analysis 
of the mucosal microbiota revealed a significant drop in species richness, an increase in 
Enterobacteriaceae, a decrease in Clostridiales, and significant changes in several other 
previously unidentified taxa. Importantly, these dysbiotic signatures were lost when stool 
samples were examined128. Intriguingly, a laser-capture microdissection study of colon crypt 
mucus in patients with ulcerative colitis found that they had lower levels of crypt-associated 
bacteria132. Overall, these studies highlight that distinguishing between fecal and mucosal 
microbial communities is particularly important for finding a reproducible microbial 
signature of IBD. Moving from correlations to a potential causal etiology of the microbiota 
for IBD and other disorders will require further study of mucosal communities, focusing on 
the interactions between the host and microbiota.
Biogeographical changes in the gut microbiota may also influence liver function. Hepatic 
encephalopathy is a neuropsychiatric complication of cirrhosis and direct sequelae of gut 
dysbiosis. As a result of impaired liver function and the presence of porto-systemic shunts 
(bypass of the liver by the circulatory system), toxic metabolites produced by the gut 
microbiota evade liver catabolism and cross the blood-brain barrier, leading to cerebral 
toxicity123. Interestingly, a comparison of the fecal microbiota of cirrhotic patients with and 
without hepatic encephalopathy showed minimal differences, whereas analyzing the 
microbiota composition of the colonic mucosa revealed significant changes, including lower 
Roseburia and higher Enterococcus, Veillonella, Megasphaera, Burkholderia, and 
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Bifidobacterium in cirrhotic patients with hepatic encephalopathy133. The bacterial genera 
over-represented in the mucosa of patients with hepatic encephalopathy (Megaspheara, 
Veillonella, Burkholderia, and Bifidobacterium) were also correlated with poor cognition, 
higher inflammation, and higher clinical severity score. In summary, mucosal dysbiosis in 
the gut, but not in the composition of the fecal community, significantly correlates with the 
severity of chronic liver disease phenotypes, including hepatic encephalopathy.
CONCLUSION
We have highlighted evidence that the microbiota is biogeographically stratified within the 
gut on different spatial scales and axes. Progress towards a functional understanding of the 
microbiota necessitates increased attention to microhabitats within the gut ecosystem, and to 
spatial relationships between microorganisms and between microorganisms and the host. 
Fecal community profiling enabled by next-generation sequencing provides a valuable 
picture of the diversity, specificity, stability, and developmental dynamics of the gut 
microbiota, but focusing on measurements of abundance in feces neglects the importance of 
mucus and tissue-associated organisms and cannot account for spatial distributions. 
Similarly, studies in gnotobiotic animals allow a reductionist approach to studying host-
microorganism interactions akin to methods traditionally employed by microbiologists 
studying pathogens, but this simplified methodology is likely to miss important 
contributions from interspecies interactions. The functional study of gut microbial ecology 
using “meta-omics” techniques enables one to account for the behaviors of the community 
as a whole, but attributing functions to particular microbial members remains a challenge in 
community-level ecology. Therefore, testing unifying hypotheses using both reductionist and 
ecological approaches will be essential to our understanding of the microbiota and its 
biological functions.
More than half a century ago, in “Microorganisms Indigenous to Man,” the microbiologist 
Theodor Rosebury lamented on the lack of a general theory for influences that control 
composition of the microbiota, the roles of individual members, and functions that affect the 
host134. With the true complexity of the problem revealed recently by sequencing advances, 
research is only now in a position to fulfill Rosebury’s call for a general theory. Rolf Freter’s 
nutrient niche hypothesis135, which states that limiting nutrients control the population level 
of species that are particularly adept at utilizing them, provides a metabolic foundation to 
explain some of the nascent observations in the field. But when Freter proposed his ideas, 
we were unaware of the role of immunomodulation by non-pathogens, which requires access 
to the tissue. Based on evidence outlined in this review, we propose that the host presents 
limiting nutrients as well as attachment sites in privileged locations. Furthermore, the 
immune system has an active role in allowing only beneficial species to access these 
locations during homeostasis. Selection for particular species close to the epithelium creates 
protected, stable reservoirs for microorganisms to persist in the face of rapidly changing 
conditions in the gut lumen. Through localized, immune-facilitated, and adherence-
dependent nutrient selection, the host maintains stability of a diverse community of 
microbial symbionts.
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Glossary
Symbionts in ecology, these are organisms that participate in a close 
relationship with other organisms. The term symbionts 
encompasses organisms that participate in different types of 
relationships, including mutualists, commensals and parasites.
Mutualists in ecology, these are organisms that participate in a symbiotic 
relationship in which both parties benefit.
Commensals in ecology, these are organisms that participate in a symbiotic 
relationship in which one party benefits from the other without 
affecting it. Historically, commensals is also used as a term for the 
resident gut bacteria, though many of these may be mutualists
Pathobiont a symbiont with the potential to promote pathology under 
conditions that deviate from homeostasis, (such as in 
immunocompromised or nutrient deprived individuals)
Indigenous organisms that are native to a particular habitat (also termed 
autochthonous), as distinct from organisms that are simply passing 
through a habitat (allochthonous)
Dysbiosis deviations from a normal microbial community, such as 
imbalances in abundance, membership or localization of 
microorganisms.
Gnotobiotic usually refers to formerly germ-free animals that carry a defined 
microbiota. The composition of the microbiota in these animals is 
usually determined experimentally.
Paneth cells specialized epithelial cells at the base of crypts in the small 
intestine that secrete antimicrobial peptides.
Goblet cells specialized epithelial cells throughout the gastroinstestinal tract 
that secrete gel-forming mucins. Goblet cells can also be present in 
other mucosal epithelial surfaces throughout the body.
Colonization 
resistance
the prevention of invasion of an exogenous species into a microbial 
community. In the gut, colonization resistance may be a result of 
resource competition, spatial exclusion or direct inhibition by 
commensal microorganisms or of selection mediated by host 
factors.
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Microaerophilic obligate aerobic microorganisms that only thrive in environments 
with relatively low oxygen concentrations, such as at the epithelial 
surface in the gut.
Microbiota The microorganisms that inhabit a particular habitat
Syntrophic A metabolic relationship between difference species in which one 
feeds another
Prebiotics Foods that stimulate the growth of commensal or mutualistic gut 
bacteria
Biofilm An aggregation of bacteria stuck to each other and to a surface
Digesta The bulk of dietary fibers that is digested as it transits the 
gastrointestinal tract
MUC2 The most abundant mucin protein in the human gut (also in mice, 
where it is referred to as Muc2).
Secreted 
Immunoglobulin A 
(sIgA)
By far the most abundant class of antibody found in the gut
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Online summary
The gut microbiota is spatially stratified along the longitudinal and cross-sectional axes 
of the gut. Chemical and nutrient gradients, antimicrobial peptides, and physical features 
of the gut contribute to differences in microbial community composition in different 
locations.
The mucosal and lumenal microbiota of the gut represent distinct microbial communities. 
On a smaller scale, patchiness within these communities suggests that they are highly 
spatially organized.
Diet imparts a large effect on microbial colonization and relative abundance, but some 
bacteria can thrive independently of dietary changes by living on host-derived nutrients 
such as mucin glycans. Therefore, the mucus layer can harbor a reservoir of bacteria that 
are maintained regardless of food intake. The appendix and colon crypts may also be 
examples of such microbial reservoirs.
Only a subset of gut symbionts are able to access the epithelial surface. Mucus, 
antimicrobial peptides, and adaptive immune activity limit tissue accessibility. Direct 
interfacing between the host and microbial symbionts may be important for maintenance 
of homeostasis.
Immunomodulation by certain symbionts allows the host to tolerate intimate relationships 
with potentially beneficial microorganisms. This may be a way in which commensals 
distinguish themselves from pathogens and prevent their elimination by the immune 
system.
While many diseases have been associated with dysbiosis, understanding the function of 
the microbiota in health and disease requires accounting for the biogeography of the 
community. Recent human studies have found differences specific to the mucosal 
community in cases of inflammatory bowel disease and hepatic encephalopathy.
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Figure 1. Microbial habitats in the human lower gastrointestinal tract
The dominant bacterial phyla in the gut are the Bacteroidetes, Firmicutes, Actinobacteria, 
Proteobacteria and Verrucomicrobia. The dominant bacterial families of the small intestine 
and colon reflect physiological differences along the length of the gut. For example, a 
gradient of oxygen, antimicrobial peptides (including bile acids, secreted by the bile duct), 
and pH limits the bacterial density in the small intestinal community, whereas the colon 
carries high bacterial loads. In the small intestine, Lactobacillaceae and Enterobacteriaceae 
dominate, whereas the colon is characterized by the presence of Bacteroidaceae, 
Prevotellaceae, Rikenellaceae, Lachnospiraceae and Ruminococcaceae. A cross-section of 
the colon shows the digesta – which is dominated by Bacteroidaceae, Prevotellaceae and 
Rikenellaceae – and the inter-fold regions of the lumen – which are dominated by 
Lachnospiraceae and Ruminococcaceae.
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Figure 2. The mucus layers of the small intestine and colon
Several factors limit the ability of gut bacteria to access host cells, including the mucus 
layers in the small intestine and the colon; antimicrobial peptides in the small intestine, 
including those produced by Paneth cells at the base of the crypts; secreted immunoglobulin 
A (sIgA) in both the small intestine and colon; and a steep oxygen gradient that influences 
which bacteria are capable of surviving close to the epithelial surface. A) The surface of the 
small intestine is shaped into villi and crypts and is colonized by certain adherent species, 
including segmented filamentous bacteria (SFB), Lactobacillaceae and Helicobacter spp. B) 
The colon has two distinct mucus structures: the outer layer is colonized by mucin-
degrading bacteria and is characterized by the presence of Bacteroides acidifaciens, 
Bacteroides fragilis, Bifidobacteriaceae and Akkermansia muciniphila and the inner layer 
and crypts are penetrated at low density by a more restricted community that includes 
Bacteroides fragilis and Acinetobacter spp.
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Figure 3. Bacterial colonization determinants
Several factors affect the localization of bacteria within the gastrointestinal tract, including 
the ability to utilize different glycans and to resist antimicrobial peptides (AMPs). A) Sus-
like systems in Bacteroides species allow the utilization of complex polysaccharides from 
the diet or the host. The figure illustrates a generalized schematic of a Sus-like system. 
Homologues of SusD and other outer membrane lipid-anchored enzymes bind and cleave the 
glycans (such as starch) into smaller oligosaccharides that are then imported by the SusC-
like outer membrane transporter. Interaction with the cognate glycan often leads to 
transmembrane signaling to activate gene regulatory mechanisms, such as a two-component 
system or a transmembrane anti-sigma factor which releases and activates a sigma factor. 
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Downstream transcriptional regulation allows Bacteroides species to respond to local 
availability of glycans. B) Cationic AMPs in the small intestine, which also pass into the 
colon via the fecal stream, disrupt bacterial outer membranes by interacting with negative 
charges on their surface. By removing phosphate groups from lipid A of lipopolysaccharide 
(LPS), pathogens and commensals alike – such as Helicobacter pylori, Salmonella spp., and 
various Firmicutes and Bacteroidetes –reduce the negative charge on their membranes and 
evade attack by cationic AMPs.
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Figure 4. Bacterial access to the epithelium
Both bacterial pathogens (red) and commensals (or mutualists; blue) have the ability to cross 
the mucus layer and access the gut epithelium. Lectins and other mucus-binding proteins 
facilitate initial interactions with the mucus layer. Mucinases and proteases are used to 
degrade mucus for bacteria to “eat” their way through, while some pathogens such as 
Salmonella spp. use flagella to swim through the viscous mucus. TLR5 sensing of flagellin 
effectively leads to inhibition of flagellar biosynthesis for most bacteria in the gut. 
Adherence to the tissue is achieved by both commensals and pathogens through pili, lectins, 
and other outer-membrane proteins that target ligands on the epithelial cell surface. 
Adherence facilitates gut colonization for both commensals and pathogens, and also allows 
tissue invasion by pathogenic bacteria. Microfold cells (M cells) are specialized immune 
sentinel epithelial cells that detect gut bacteria and are also exploited by many pathogens as 
a means of translocation across the epithelium.
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Figure 5. Immunomodulation by commensal gut bacteria
Commensal gut bacteria induce immunomodulation via interaction with epithelial cells, 
antigen presenting cells (such as dendritic cells (DCs)), and via production of signaling 
metabolites. The exopolysaccharides of adherent Bifidobacterium breve reduce the 
production of inflammatory cytokines to dampen B cell responses. The capsular 
polysaccharide PSA of Bacteroides fragilis and short-chain fatty acids (SCFAs) produced by 
many species of Clostridia (and other genera) stimulate the production of the anti-
inflammatory interleukin-10 (IL-10) by regulatory T cells. Segmented filamentous bacteria 
(SFB) intercalate between microvilli of epithelial cells and stimulate the development of 
Th17 cells, which are important for mucosal immunity to extracellular pathogens.
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Figure 6. Gut microhabitats as reservoirs of bacterial diversity
Specific niches such as crypts, the inner mucus, and the appendix may be crucial to facilitate 
immune homeostasis, to protect microbial inhabitants from competitors, and to re-populate 
the gut following perturbations that alter bacterial community structure or deplete certain 
species from the lumen. A) A subset of species is able to penetrate the inner mucus layer and 
enter crypt spaces. B) Environmental challenges such as diet perturbations, abnormalities in 
gastrointestinal motility, and antibiotic consumption massively alter the lumen community. 
However, the more stable mucosal environment and crypts protect important bacterial 
species. C) The crypts and mucosa serve as reservoirs to repopulate the lumen.
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